Arcus Biosciences (RCUS) Receivables - Other (2017 - 2025)
Arcus Biosciences (RCUS) has 9 years of Receivables - Other data on record, last reported at $11.0 million in Q4 2025.
- For Q4 2025, Receivables - Other changed N/A year-over-year to $11.0 million; the TTM value through Dec 2025 reached $11.0 million, changed N/A, while the annual FY2025 figure was $11.0 million, N/A changed from the prior year.
- Receivables - Other reached $11.0 million in Q4 2025 per RCUS's latest filing, roughly flat from $11.0 million in the prior quarter.
- Across five years, Receivables - Other topped out at $38.0 million in Q4 2023 and bottomed at -$715.0 million in Q1 2022.
- Average Receivables - Other over 5 years is -$28.0 million, with a median of $5.0 million recorded in 2024.
- The widest YoY moves for Receivables - Other: up 2451.43% in 2022, down 13758.07% in 2022.
- A 5-year view of Receivables - Other shows it stood at $17.3 million in 2021, then crashed by 76.91% to $4.0 million in 2022, then surged by 850.0% to $38.0 million in 2023, then plummeted by 92.11% to $3.0 million in 2024, then soared by 266.67% to $11.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Other were $11.0 million in Q4 2025, $11.0 million in Q3 2025, and $15.0 million in Q2 2025.